48.58
price down icon0.23%   -0.159
 
loading
Precedente Chiudi:
$48.74
Aprire:
$48.57
Volume 24 ore:
635.94K
Relative Volume:
0.24
Capitalizzazione di mercato:
$117.70B
Reddito:
$43.23B
Utile/perdita netta:
$6.79B
Rapporto P/E:
12.13
EPS:
4.0051
Flusso di cassa netto:
$9.17B
1 W Prestazione:
+0.56%
1M Prestazione:
-2.51%
6M Prestazione:
+0.66%
1 anno Prestazione:
+0.83%
Intervallo 1D:
Value
$48.57
$48.75
Intervallo di 1 settimana:
Value
$48.26
$48.95
Portata 52W:
Value
$44.62
$60.12

Sanofi Adr Stock (SNY) Company Profile

Name
Nome
Sanofi Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
82,878
Name
Cinguettio
@sanofi
Name
Prossima data di guadagno
2025-10-24
Name
Ultimi documenti SEC
Name
SNY's Discussions on Twitter

Confronta SNY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
SNY
Sanofi Adr
48.58 118.09B 43.23B 6.79B 9.17B 4.0051
Drug Manufacturers - General icon
LLY
Lilly Eli Co
1,076.34 966.40B 59.42B 18.41B 6.44B 20.22
Drug Manufacturers - General icon
JNJ
Johnson Johnson
207.13 498.51B 92.15B 25.12B 20.46B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
229.24 406.04B 59.64B 2.36B 19.68B 1.3253
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
137.97 266.17B 54.45B 14.42B 17.15B 7.333
Drug Manufacturers - General icon
MRK
Merck Co Inc
105.22 263.24B 63.90B 19.05B 13.05B 7.5596

Sanofi Adr Stock (SNY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-12-09 Downgrade Guggenheim Buy → Neutral
2025-12-08 Downgrade JP Morgan Overweight → Neutral
2025-09-08 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2025-09-02 Aggiornamento Deutsche Bank Hold → Buy
2025-08-08 Aggiornamento JP Morgan Neutral → Overweight
2025-04-15 Iniziato Exane BNP Paribas Outperform
2025-03-21 Iniziato Goldman Neutral
2025-01-30 Aggiornamento Deutsche Bank Sell → Hold
2024-07-26 Reiterato Argus Buy
2024-01-23 Iniziato Morgan Stanley Equal-Weight
2024-01-16 Ripresa UBS Buy
2023-12-05 Downgrade JP Morgan Overweight → Neutral
2023-10-30 Downgrade Stifel Buy → Hold
2023-09-06 Aggiornamento Berenberg Hold → Buy
2023-07-14 Iniziato HSBC Securities Buy
2023-04-28 Downgrade Deutsche Bank Hold → Sell
2023-03-27 Aggiornamento Barclays Equal Weight → Overweight
2022-12-13 Ripresa Morgan Stanley Overweight
2022-08-12 Aggiornamento Deutsche Bank Sell → Hold
2022-08-09 Downgrade UBS Buy → Neutral
2022-05-23 Iniziato SVB Leerink Outperform
2021-09-27 Aggiornamento SVB Leerink Mkt Perform → Outperform
2021-01-15 Iniziato Deutsche Bank Sell
2020-09-29 Iniziato Berenberg Hold
2020-03-17 Aggiornamento Barclays Underweight → Equal Weight
2020-03-11 Aggiornamento Goldman Neutral → Buy
2020-02-11 Iniziato SVB Leerink Mkt Perform
2020-01-06 Aggiornamento JP Morgan Neutral → Overweight
2019-09-23 Aggiornamento Guggenheim Neutral → Buy
2019-09-20 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2019-09-03 Iniziato Bernstein Outperform
2019-08-14 Aggiornamento UBS Neutral → Buy
2018-12-11 Aggiornamento Jefferies Hold → Buy
2018-11-01 Aggiornamento Barclays Underweight → Equal Weight
2018-10-09 Iniziato Guggenheim Neutral
2018-09-10 Aggiornamento BofA/Merrill Neutral → Buy
2018-08-10 Aggiornamento Citigroup Neutral → Buy
2018-03-23 Aggiornamento Liberum Hold → Buy
2018-01-23 Downgrade Barclays Equal Weight → Underweight
2017-12-06 Downgrade BofA/Merrill Buy → Neutral
2017-12-01 Downgrade Morgan Stanley Overweight → Underweight
2017-11-15 Aggiornamento Barclays Underweight → Equal Weight
2017-08-30 Aggiornamento HSBC Securities Reduce → Hold
Mostra tutto

Sanofi Adr Borsa (SNY) Ultime notizie

pulisher
08:59 AM

Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026 - Benzinga

08:59 AM
pulisher
Dec 30, 2025

Jefferies Maintains Buy on Sanofi (SNY) Despite Regulatory Overhang - Finviz

Dec 30, 2025
pulisher
Dec 30, 2025

Where is Sanofi (SNY) Headed According to Wall Street? - Finviz

Dec 30, 2025
pulisher
Dec 29, 2025

Delayed MS Decision and Trial Miss Add to Sanofi's R&D Challenges - Finviz

Dec 29, 2025
pulisher
Dec 28, 2025

Sanofi (SNY) to Acquire Dynavax Technologies Corporation (DVAX) - Finviz

Dec 28, 2025
pulisher
Dec 25, 2025

Total debt per share of Sanofi SA Sponsored ADR – LSE:0A2V - TradingView — Track All Markets

Dec 25, 2025
pulisher
Dec 24, 2025

Why Dynavax Stock Soared Today - Finviz

Dec 24, 2025
pulisher
Dec 24, 2025

Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise - Finviz

Dec 24, 2025
pulisher
Dec 24, 2025

Sanofi Makes $2.2 Billion Bet On Adult Vaccines With Dynavax Buy - Sahm

Dec 24, 2025
pulisher
Dec 24, 2025

Our Environmental Impact - Sanofi

Dec 24, 2025
pulisher
Dec 21, 2025

Bloom Energy Aktie: KI-Boom trifft auf Energiekrise! - Finanztrends

Dec 21, 2025
pulisher
Dec 17, 2025

Sanofi (SNY) Shares Under Pressure After JPMorgan and Guggenheim Downgrades - Finviz

Dec 17, 2025
pulisher
Dec 16, 2025

FOLD Shares Hit 52-Week High: Time to Buy, Sell or Hold the Stock? - Finviz

Dec 16, 2025
pulisher
Dec 15, 2025

Sanofi (SNY) sees slight pessimism from analysts - MSN

Dec 15, 2025
pulisher
Dec 15, 2025

Sanofi: Today's Tolebrutinib Setback Shouldn't Worry ShareholdersThis Is Why (SNY) - Seeking Alpha

Dec 15, 2025
pulisher
Dec 15, 2025

Sanofi Expands Dren Bio Partnership With Potential $1.7 Billion Autoimmune Disease Collaboration - Sahm

Dec 15, 2025
pulisher
Dec 15, 2025

Sanofi's Multiple Sclerosis Drug Faces Trial And Regulatory Setbacks - Sahm

Dec 15, 2025
pulisher
Dec 15, 2025

Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025) - ts2.tech

Dec 15, 2025
pulisher
Dec 14, 2025

SNY Stock Price and Chart — NASDAQ:SNY - TradingView — Track All Markets

Dec 14, 2025
pulisher
Dec 12, 2025

Sanofi (SNY) Sees Slight Pessimism From Analysts - Finviz

Dec 12, 2025
pulisher
Dec 10, 2025

JPMorgan Downgrades Sanofi (SNY) to EUR 95 from EUR 105 - Finviz

Dec 10, 2025
pulisher
Dec 10, 2025

TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia - Finviz

Dec 10, 2025
pulisher
Dec 10, 2025

Why Wall Street Analysts Are Closely Watching Sanofi (SNY) - Finviz

Dec 10, 2025
pulisher
Dec 09, 2025

Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play - Finviz

Dec 09, 2025
pulisher
Dec 09, 2025

KYMR Stock Surges on Upbeat Data From KT-621 Atopic Dermatitis Study - Finviz

Dec 09, 2025
pulisher
Dec 09, 2025

Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks - Sahm

Dec 09, 2025
pulisher
Dec 01, 2025

REGN Gains 21.5% in a Month: Time to Buy, Sell or Hold the Stock? - Finviz

Dec 01, 2025
pulisher
Nov 28, 2025

Deutsche Bank Maintains a Buy Rating on Sanofi (SNY) - Finviz

Nov 28, 2025
pulisher
Nov 26, 2025

Kymera Trades Near 52-Week High: Time to Buy, Sell or Hold the Stock? - Finviz

Nov 26, 2025
pulisher
Nov 25, 2025

SNY & REGN's Dupixent Gets EU Nod for Chronic Spontaneous Urticaria - Finviz

Nov 25, 2025
pulisher
Nov 25, 2025

Sanofi Faces Surprise HQ Search As French Authorities Expand Tax Probe - Sahm

Nov 25, 2025
pulisher
Nov 23, 2025

Bloom Energy-Aktie: Vorsicht geboten! - Finanztrends

Nov 23, 2025
pulisher
Nov 22, 2025

Abbott-Aktie: 21 Milliarden Dollar für neues Wachstum! - Finanztrends

Nov 22, 2025
pulisher
Nov 21, 2025

Texas AG Sues Sanofi And Bristol-Myers Over Alleged Failures To Warn About Risks Associated With Blood Thinner Drug - Sahm

Nov 21, 2025
pulisher
Nov 21, 2025

Wasserstoff-Aktien: Bloom Energy kollabiert erneut, Nel ASA gibt nicht auf und Primary Hydrogen meldet Fortschritte! - Finanztrends

Nov 21, 2025
pulisher
Nov 21, 2025

A Technical View of the Leifras Co Ltd ADR (LFS) - fostersleader.com

Nov 21, 2025

Sanofi Adr Azioni (SNY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general PFE
$24.91
price down icon 0.26%
$122.92
price down icon 0.09%
$327.50
price down icon 0.26%
drug_manufacturers_general NVO
$51.01
price down icon 0.42%
drug_manufacturers_general MRK
$105.08
price down icon 0.82%
Capitalizzazione:     |  Volume (24 ore):